-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Management Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Limited Liability Clause
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
- Monitoring and Evaluation
- Principal Recipient Start-Up
-
Procurement and Supply Management
- Development of List of Health Products and Procurement Action Plan
- Distribution and Inventory Management
- Overview
- Price and Quality Reporting (PQR) System
- Procurement of Non-health Products and Services
- Procurement of Pharmaceutical and Other Health Products
- Quality Control
- Rational use of Medicines and Pharmacovigilance Systems
- Strengthening of PSM Services and Risk Mitigation
- UNDP Health PSM Roster
- UNDP Quality Assurance Policy and Plan
-
Reporting
- Communicating Results
- Grant Performance Report
- Overview
- Performance-based Funding and Disbursement Decision
- PR and Coordinating Mechanism (CM) Communication and Governance
- Reporting to the Global Fund
- UNDP Corporate Reporting
-
Risk Management
- Common Risks Identified in Global Fund Programmes
- Global Fund Risk Management
- Introduction to Risk Management
- Overview
- Risk Management in High Risk Environments
- Risk Management in UNDP-managed Global Fund Grants
- Risk management in UNDP
- UNDP Risk Management in the Global Fund Portfolio
- Sub-Recipient Management
Non-pharmaceutical Health Products
Reproductive health commodities (including condoms)
UNDP Country Offices (COs) are advised to procure this category of products via the United Nations Population Fund (UNFPA). All items in the UNFPA catalogue can be procured through UNFPA. The Memorandum of Understanding (MoU) between UNDP and UNFPA, which can be accessed here.
According to the latest Standard Operating Procedures (SOPs) for using commercial long-term agreements (LTAs), there are some cases when COs can approach commercial LTAs—namely, when:
- UNFPA cannot provide the product in time, with specific labeling and language requirements, or in the volume or unit size required; and
- UNFPA has not responded within two weeks of the request for a cost estimate being made.
The SOPs for using commercial LTAs can be found here.
Diagnostic/laboratory/medical supplies, consumables and equipment
UNDP COs/PMUs are advised to procure this category of products via the UNDP Procurement Services Unit (PSU)/Global Procurement Unit (GPU) through the existing Service Level Agreement (SLA) between the UNDP Global Fund/Health Implementation Team and PSU/GPU. UNICEF and the commercial LTA holders can be used as a backup option under the same conditions as mentioned in SOPs for using commercial LTA holders. If the situation warrants it, the UNDP CO may undertake its own competitive process, upon consultation with and prior approval from the UNDP Global Fund/Health Implementation Support Team.
- For a number of rapid diagnostic tests (RDTs), WHO LTAs are available for direct use by UNDP. These LTAs may be considered as an alternative option for use by requesting units upon consultation with and prior approval from the UNDP Global Fund/Health Implementation Support Team.
Blood-related items
UNDP COs are advised to consult with Sr. Health PSM Advisor, Cécile Mace for procurement of blood related products in coordination with Jean Michel Caudron (Pharmacist) for technical support.
Bed nets
UNDP COs are advised to procure this category of products via the UNICEF Supply Division.
Indoor residual spraying (IRS)
UNDP COs are advised to procure this category of products via UNDP PSU/GPU.
When procurement actions are channelled through any of the options outline above, COs do not need to enter into separate tender exercises for price comparison purposes or to obtain further internal approvals (Contract, Asset and Procurement (CAP) and/or Advisory Committee on Procurement (ACP) approval). These processes have already been completed prior to the establishment of those LTAs, by the respective organizations/units, in accordance with their internal United Nations procurement rules and regulations.
It is important, however, for requesting units to observe the SOPs developed by the UNDP Global Fund/Health Implementation Support Team for each of the sourcing options outlined above and to consult with the Team on any questions that may arise. It is equally important to adhere to the reporting instructions provided to ensure that the Team can to properly monitor the use of LTAs, as requested by UNDP Chief Procurement Officer (CPO), PSU and Bureau for Policy and Programme Support (BPPS) Senior Management.
For all the above categories (reproductive health commodities, medical devices, bed nets and IRS), when United Nations agencies are unable to assist with procurement of commodities, alternative arrangements will need to be made to procure products compliant with UNDP quality assurance (QA) requirements. In this case, the UNDP Global Fund/Health Implementation Support Team will need to be informed and will then advise on how to proceed.